Full Text (PDF)
Original Article

Evaluation of Safety and Efficacy of Quick Penetrating Heparin Solution (1000 IU/ml) in Prevention of Intravenous Cannula Related Thrombophlebitis: A Prospective, Randomized, Comparative, Parallel Group Clinical Study

Jaimin M Pandya , Jaimin M Pandya1 , Shiwalika Gupta2 , Amit Chouhan3 , Himanshu Shah4 , Sudha Shah5 , Ashish Jain6

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 6(6):p 2129-2132, November-December 2019. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6619.39

How Cite This Article:

Jaimin M Pandya, Shiwalika Gupta, Amit Chouhan et al. Evaluation of Safety and Efficacy of Quick Penetrating Heparin Solution (1000 IU/ml) in Prevention of Intravenous Cannula Related Thrombophlebitis: A Prospective, Randomized, Comparative, Parallel Group Clinical Study. Indian J Anesth Analg. 2019;6(6 Part -II):2129-2132.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background and Aims: To evaluate the safety and efficacy of marketed heparin sodium topical solution (1000 IU/ml) compared to no heparin topical treatment group for prevention of infusion associated thrombophlebitis. Methods: A prospective, randomized, parallel group, comparative, single centre, clinical study. A total 100 patients undergoing intravenous cannulation that has been planned to remain in situ for at least 48 hours indoor period were enrolled. Patients were randomized in Group A (Heparin Topical solution) vs Group B (No Heparin Topical solution). Investigational product was applied on skin around dressing covering intravenous cannulation site approximately every 8 hours for the treatment period of 48 hours. Patients were evaluated for incidences of infusion phlebitis, first signs of phlebitis and treatment emergent application site reactions and were statistically analyzed for statistical significance, p - value below 0.05 levels was considered to be significant. Results: Incidences of infusion phlebitis Grade 2 was found to be higher in “no treatment group” than in “Topical Heparin Group” (20 vs 6 patients; p = 0.00205). Incidences of first sign of phlebitis grade was found to be higher in “no treatment group” than in “Topical Heparin Group” (48 vs 25 patients; p = 0.000). Time to develop first sign of phlebitis was lesser in “No Treatment Group” than in Topical Heparin Group (26 hr vs 36 hr; p = 0.0023). Also, none of the patient in the Heparin Group develop the thrombophlebitis (Grade IV- advance stage of phlebitis). Conclusions: Topical solution of Heparin Sodium 1000 IU/ml was found to be effective and safe in preventing infusion related phlebitis.


References

No records found.


About this article


Cite this article

Jaimin M Pandya, Shiwalika Gupta, Amit Chouhan et al. Evaluation of Safety and Efficacy of Quick Penetrating Heparin Solution (1000 IU/ml) in Prevention of Intravenous Cannula Related Thrombophlebitis: A Prospective, Randomized, Comparative, Parallel Group Clinical Study. Indian J Anesth Analg. 2019;6(6 Part -II):2129-2132.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6619.39

Keywords

Heparin Topical solution; Superficial thrombophlebitis; Infusion associated thrombophlebitis.

Article Level Metrics

Last Updated

Monday 13 July 2026, 05:09:36 (IST)


5647

Accesses

6
678
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share